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INTRODUCTION
Antibiotics can enter the environment through different 
routes. Antibiotics produced by industry as well as their 
metabolites are released from plants, hospitals, farms, 
and households with biological wastes (urine, faeces, 
sputum, placenta, tissues and organs) or by means of 
abandoned animals (e.g., cattle in India), stray animals 
(dogs, pigs, and birds) and open human defecation in 
slum areas. From the sewage, waste water treatment 
plants (WWTPs), and surface run off the antibiotics and/or 
ARG contaminate water and can be dispersed on fields 
that directly or indirectly enter humans’ and animals’ food 
chain systems. 
Figure 1. Schematics of major facilitations for 

















Illustration of the major players involved in exchanges and 
interaction with both antibiotics and the environment surrounding 
them to signify the transmission paths in which bacteria are able 
to develop ARG mutations.
METHODS & ANALYSIS
The method for this study is an analysis of pathways that were 
previously published. In order to justify the comprehensive and 
educative nature of this review over two hundred sources were 
used to build a strong foundation from collection, analyses, and 
interpretation of both qualitative and quantitative data.




















































*30 years since a new 










































































































































TIMELINE OF 100 YEARS OF ANTIBIOTIC  DISCOVERIES
This figures depicts three major details to note; the beginning of 
antibiotics development, followed by the discovery of pe icillin there is 
a surge of antibiotics discovery between 60’s and 80’s, decline in 
antibiotics development between late 80’s and 90’s, and the void in 
new antibiotics classifications. 
MAJOR FINDINGS
The completed and published review paper highlights many 
important aspects with regards to nutrition and the 
environment. Four major aspects of the review that are ideal 
for discussion would be the void in antibiotics discovery, 
evolution of antibiotic resistance, antibiotic uses, and others. 
Table 2. Mechanism of action of antibiotics
Table 1. Classification of antibiotic resistance threats
Microorganisms are able to develop antibiotic-resistant genes to 
enhance their survival, thus minimizing the treatment options for 
microbial infections and increasing mortality in human populations. 
Antibiotic resistance is classified into three categories based on the 
threat: urgent, serious, and concerning. 
This table contains antibiotics that are routinely prescribed to patients. 
Even though they have been tested for their efficacy and benefits, the 
haphazard uses are underestimated, hence the debilitating effects 
caused antibiotics in humans are often condoned. 
Table 3. Antibiotic resistant genes (ARG) in animal 
production settings
This table illustrates the bacteria present, how it is introduced to 
humans for infections, and the use of antimicrobial substances in 
animal production for food. 
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These findings are significant, especially with the context of 
an overall 176% increase in antibiotic use was observed 
during the decade 2000–2010 in Brazil, Russia, India, China, 
and South Africa (BRICS). 
Continuing on this point, animal consumption of 
antimicrobials in BRICS countries is expected to increase up 
to 199% by 2030 compared to current use. In human 
populations its expected growth will be around 113% during 
the same period. Moreover, with respect to figure 1, it begs to 
scrutinize the various environments that bacteria can 
penetrate, interact, proliferate by spreading, and building 
antibiotic resistance among both animals and humans. 
In order to mitigate and combat infectious pathogens 
containing ARG, there are several mediations that are being 
explored and implemented.
CONCLUSION 
Antibiotics became a part of modern medicine around seven 
decades ago and their efficacy and safety do not meet the 
demands of the intensifying animal production and growing 
human population, facing the global threat of infectious 
diseases. Experts from diverse fields such as clinical research, 
microbiology, genetic and computational engineering, imaging 
and modelling should work jointly to evolve strategies and 
develop novel therapeutics to address this problem.
DISCUSSION
There are many emerging therapies and prospective 
strategies that are being explored or implemented. Some of 
which will be discussed below. 
Table 4. Effect of essential oils against bacteria.
Figure 4. Nanoantibiotics mechanism for ARGs 
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Figure 2. Mechanisms of horizontal and vertical 
transmission in bacteria
Horizontal transmission of an antibiotic resistant gene depicted by 
conjugation, transformation, and transduction. The right-hand side 
of the figure shows the vertical evolution carried out by bacteria 
replication containing the ARG. 
Essential oils are a type of secondary metabolites of aromatic plants. 
Liquid and volatile essential oils have significant medicinal properties 
in infectious and non-infectious diseases and have a low risk of 
antibiotic resistance. 
Principle of action 
by nano-antibiotic 
therapies including 
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and death of 
bacteria. 
